Skip to content

Commit

Permalink
made cards fo external ear
Browse files Browse the repository at this point in the history
  • Loading branch information
kamranmuazzam committed Dec 10, 2024
1 parent 92966b7 commit 3a4c794
Show file tree
Hide file tree
Showing 138 changed files with 10,479 additions and 513 deletions.
8 changes: 5 additions & 3 deletions .obsidian/workspace.json
Original file line number Diff line number Diff line change
Expand Up @@ -13,12 +13,12 @@
"state": {
"type": "markdown",
"state": {
"file": "pages/Wax.md",
"file": "logseq/bak/pages/Acute Maxillary Sinusitis/2024-12-09T11_06_23.310Z.Desktop.md",
"mode": "source",
"source": false
},
"icon": "lucide-file",
"title": "Wax"
"title": "2024-12-09T11_06_23.310Z.Desktop"
}
}
]
Expand Down Expand Up @@ -52,7 +52,7 @@
"state": {
"type": "search",
"state": {
"query": "",
"query": "tag:#ent-prof-card",
"matchingCase": false,
"explainSearch": true,
"collapseAll": false,
Expand Down Expand Up @@ -165,6 +165,8 @@
},
"active": "e9eec337ac40e078",
"lastOpenFiles": [
"pages/Syringing the Ear.md",
"pages/Wax.md",
"journals/2024_12_09.md",
"pages/Perichondritis.md",
"pages/Otomycosis.md",
Expand Down
Original file line number Diff line number Diff line change
@@ -0,0 +1,90 @@
- alias::
ICD-11_Code::
- ## Etiology
background-color:: blue
- ### Causative Agents
- ### Risk Factors
- ## Epidemiology
background-color:: blue
- ### Incidence
- ### Prevalence
- ### Demographics
- ### Geographic Distribution
- ## Pathophysiology
background-color:: blue
- ### Mechanism of Disease
- ### Affected Systems/Organs
- ## Clinical Features
background-color:: blue
- ### Signs and Symptoms
- #### Symptoms
- #### Signs
id:: 6a809090-cfec-499d-8a53-72733578865f
- Painful per-vaginal Bleeding
- Dark Colored Blood
- Anemia out of proportion to the visible blood loss
- Often associated with Pre-eclampsia
- Uterus
- disproportionately enlarged in concealed type
- May be tense, tender and rigid
- Fetal Heart Sound absent in concealed type
- ### Stages or Classification
- ### Diagnostic Criteria
- ## Diagnosis #obspw #unanswered
background-color:: blue
- ### Clinical Diagnosis #obGyn-prof-OSPE
- Lower abdominal pain
- Per vaginal bleeding
- Uterus is hard and contracted
- FHS is absent
- ### Per Vaginal Examination
- Placenta is not felt on lower segment
- Blood clots are felt
- ### Laboratory Tests
- ### Imaging Studies
- [[Abdominal Ultrasonography]] : Placenta in upper segment
- ### Differential Diagnosis
- ## Management and Treatment #obspw #unanswered #obGyn-prof-OSPE
background-color:: blue
- Bishop's scoring
- If cervix favourable
- ### Medical Treatment
- Induction of labor by ARM and oxytocin
- if cervix is unfavourable
- ### Surgical Options
- [[Caesarean Section]]
- ### Lifestyle and Dietary Recommendations
- ## Prognosis
background-color:: blue
- ### Expected Course
- #### With Treatment
- #### Without Treatment
- ### Survival Rates
- #### With Treatment
- #### Without Treatment
- ### Quality of Life Considerations
- ## Complications #obspw #unanswered
background-color:: blue
- ### Possible Complications #obGyn-prof-OSPE
- Acute Renal Failure
- DIC
- ### Long-term Effects
- ## Prevention
background-color:: blue
- ### Health Education
- ### Community Approach
- ### Screening Programs
- ### Lifestyle Modifications
- ## Patient Education and Support
background-color:: blue
- ### Educational Resources
- ### Support Groups
- ### Counseling Options
- ## Recent Research and Developments
background-color:: blue
- ### Ongoing Clinical Trials
- ### Recent Advances
- ## Key Literature
background-color:: blue
- ## Guidelines and Protocols
background-color:: blue
Original file line number Diff line number Diff line change
@@ -0,0 +1,74 @@
- alias::
ICD-11_Code::
- ## Etiology #ent-prof-card #card
background-color:: blue
deck:: #ENT
id:: 36de9f45-68c5-4331-8e37-c3daf391bb23
- ### Causative Agents
- ### Risk Factors
- ## Epidemiology
background-color:: blue
- ### Incidence
- ### Prevalence
- ### Demographics
- ### Geographic Distribution
- ## Pathophysiology
background-color:: blue
- ### Mechanism of Disease
- ### Affected Systems/Organs
- ## Clinical Features #ent-prof-card #card
background-color:: blue
deck:: #ENT
id:: 52c64503-bf27-4d6a-8474-e752eb17a295
- ### Signs and Symptoms
- #### Symptoms
- #### Signs
- ### Stages or Classification
- ### Diagnostic Criteria
- ## Diagnosis
background-color:: blue
- ### Clinical Diagnosis
- #### Classical Presentation
- #### Probable Diagnosis
- ### Laboratory Tests
- ### Imaging Studies
- ### Differential Diagnosis
- ### Confirmation of Diagnosis
- ## Management and Treatment #ent-prof-card #card
background-color:: blue
deck:: #ENT
id:: 2d2ff087-298c-43ec-a324-fce7ddfa9dfa
- ### Medical Treatment
- ### Surgical Options
- ### Lifestyle and Dietary Recommendations
- ### Follow-up
- ## Prognosis
background-color:: blue
- ### Expected Course
- #### With Treatment
- #### Without Treatment
- ##### Possible Complications
- ##### Long-Term Effects
- ### Survival Rates
- #### With Treatment
- #### Without Treatment
- ### Quality of Life Considerations
- ## Prevention
background-color:: blue
- ### Health Education
- ### Community Approach
- ### Screening Programs
- ### Lifestyle Modifications
- ## Patient Education and Support
background-color:: blue
- ### Educational Resources
- ### Support Groups
- ### Counseling Options
- ## Recent Research and Developments
background-color:: blue
- ### Ongoing Clinical Trials
- ### Recent Advances
- ## Key Literature
background-color:: blue
- ## Guidelines and Protocols
background-color:: blue
Original file line number Diff line number Diff line change
@@ -0,0 +1,75 @@
- alias::
ICD-11_Code::
- #definition {{c1 }} #ent-prof-card #card
deck:: #ENT
id:: 6756c304-3499-4275-8d91-49419983f0cc
- ## Etiology
background-color:: blue
- ### Causative Agents
- ### Risk Factors
- ## Epidemiology
background-color:: blue
- ### Incidence
- ### Prevalence
- ### Demographics
- ### Geographic Distribution
- ## Pathophysiology
background-color:: blue
- ### Mechanism of Disease
- ### Affected Systems/Organs
- ## Clinical Features
background-color:: blue
- ### Signs and Symptoms
- #### Symptoms
- #### Signs
- ### Stages or Classification
- ### Diagnostic Criteria
- ## Diagnosis #ent-prof-card #card
background-color:: blue
deck:: #ENT
id:: 55f72805-d6eb-4212-990f-cc2cd81152c3
- ### Clinical Diagnosis
- #### Classical Presentation
- #### Probable Diagnosis
- ### Laboratory Tests
- ### Imaging Studies
- ### Differential Diagnosis
- ### Confirmation of Diagnosis
- ## Management and Treatment #ent-prof-card #card
background-color:: blue
deck:: #ENT
id:: f9d9dedb-3efc-4deb-bde8-e714cd3afa45
- ### Medical Treatment
- ### Surgical Options
- ### Lifestyle and Dietary Recommendations
- ### Follow-up
- ## Prognosis
background-color:: blue
- ### Expected Course
- #### With Treatment
- #### Without Treatment
- ##### Possible Complications
- ##### Long-Term Effects
- ### Survival Rates
- #### With Treatment
- #### Without Treatment
- ### Quality of Life Considerations
- ## Prevention
background-color:: blue
- ### Health Education
- ### Community Approach
- ### Screening Programs
- ### Lifestyle Modifications
- ## Patient Education and Support
background-color:: blue
- ### Educational Resources
- ### Support Groups
- ### Counseling Options
- ## Recent Research and Developments
background-color:: blue
- ### Ongoing Clinical Trials
- ### Recent Advances
- ## Key Literature
background-color:: blue
- ## Guidelines and Protocols
background-color:: blue
Original file line number Diff line number Diff line change
@@ -0,0 +1,110 @@
- alias::
ICD-11_Code::
- ## Etiology
background-color:: blue
- ### Causative Agents
- ### Risk Factors
- ## Epidemiology
background-color:: blue
- ### Incidence
- ### Prevalence
- ### Demographics
- ### Geographic Distribution
- ## Pathophysiology
background-color:: blue
- ### Mechanism of Disease
- ### Affected Systems/Organs
- ## Clinical Features
background-color:: blue
- ### Signs and Symptoms
- #### Symptoms #eye-prof-card #card
deck:: #Eye
id:: a8cc2e5c-90dd-4c82-8d22-14a5a66b12bb
- Mild pain
logseq.order-list-type:: number
- Photophobia
logseq.order-list-type:: number
- Redness
logseq.order-list-type:: number
- #### Signs #eye-prof-card #card
deck:: #Eye
id:: ad1ea991-9cc3-440f-9266-3be8950f0d2e
- Visual Acuity reduced
logseq.order-list-type:: number
- ### Stages or Classification
- ### Diagnostic Criteria
- ## Diagnosis
background-color:: blue
- ### Clinical Diagnosis
- #### Classical Presentation
- #### Probable Diagnosis
- ### Laboratory Tests
- ### Imaging Studies
- ### Differential Diagnosis
- [[Acute Angle Closure Glaucoma]]
id:: 67541f2a-f920-4139-bbd2-9e23ab3a42b2
- id:: 67541f3e-5249-4a44-8402-70410e14efe4
| Topic | AAU | AACG |
|------------------|--------------------------------|--------------------------------|
| Pain and vision loss | Mild pain and gradual loss of vision | Severe pain and sudden marked loss of vision |
| Circumcilliary | Mild | Moderate to severe |
| Cornea | Mild hazy | Hazy |
| Ant. Chamber | Depth Normal | Shallow |
| Cell | +++ | +/- |
| Flare | +++ | + |
| Pupil | Constricted | Mild dilated |
| IOP | Less/Normal | Increased |
| Treatment | Steroid, Mydriatics | Anti-Glaucoma Drugs |
- ### Confirmation of Diagnosis
- ## Management and Treatment
background-color:: blue
- ### Medical Treatment
- Medications
- [[Mydriatics]] Topical [[Atropine 1% Sulphate]] [[TDS]]
logseq.order-list-type:: number
- [[Steroid]] -> Topical [[Dexamethasone]]
logseq.order-list-type:: number
- Mechanism of Action of the Medications
- [[Mydriatics]] #eye-prof-card #card
deck:: #Eye
id:: 6755b7b7-3a46-45a7-aa9b-82898d07b7df
- Relief Pain
logseq.order-list-type:: number
- Prevention and also breakdown of if existing Synachae
logseq.order-list-type:: number
- [[Steroid]] -> {{c1 Reduces Inflammation}} #eye-prof-card #card
deck:: #Eye
id:: 6755b7e5-3798-4191-a163-e41954f7ce45
- ### Surgical Options
- ### Lifestyle and Dietary Recommendations
- ### Follow-up
- ## Prognosis
background-color:: blue
- ### Expected Course
- #### With Treatment
- #### Without Treatment
- ##### Possible Complications
- ##### Long-Term Effects
- ### Survival Rates
- #### With Treatment
- #### Without Treatment
- ### Quality of Life Considerations
- ## Prevention
background-color:: blue
- ### Health Education
- ### Community Approach
- ### Screening Programs
- ### Lifestyle Modifications
- ## Patient Education and Support
background-color:: blue
- ### Educational Resources
- ### Support Groups
- ### Counseling Options
- ## Recent Research and Developments
background-color:: blue
- ### Ongoing Clinical Trials
- ### Recent Advances
- ## Key Literature
background-color:: blue
- ## Guidelines and Protocols
background-color:: blue
Loading

0 comments on commit 3a4c794

Please sign in to comment.